1. Home
  2. CHOW vs LEXX Comparison

CHOW vs LEXX Comparison

Compare CHOW & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ChowChow Cloud International Holdings Limited Ordinary Shares

CHOW

ChowChow Cloud International Holdings Limited Ordinary Shares

HOLD

Current Price

$0.38

Market Cap

14.1M

Sector

Technology

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.56

Market Cap

16.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHOW
LEXX
Founded
2014
2004
Country
Hong Kong
Canada
Employees
17
7
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.1M
16.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CHOW
LEXX
Price
$0.38
$0.56
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
10.2M
65.9K
Earning Date
06-17-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$601.47
P/E Ratio
$10.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.46
52 Week High
$12.05
$1.55

Technical Indicators

Market Signals
Indicator
CHOW
LEXX
Relative Strength Index (RSI) 44.66 42.75
Support Level $0.34 $0.46
Resistance Level $0.52 $0.70
Average True Range (ATR) 0.04 0.04
MACD -0.01 0.00
Stochastic Oscillator 4.18 25.08

Price Performance

Historical Comparison
CHOW
LEXX

About CHOW ChowChow Cloud International Holdings Limited Ordinary Shares

ChowChow Cloud International Holdings Ltd provides one-stop cloud solutions that support companies across the IT industry value chain throughout their entire cloud transformation journey, from consulting, deployment, and migration to cloud environment building and management. Its business comprises (i) digital transformation consulting services consisting of cloud suitability assessment, (ii) professional IT services comprising capabilities designed to facilitate seamless cloud integration and digital transformation, (iii) AI-powered proactive cloud managed services covering all aspects of day-to-day cloud maintenance and support, and (iv) IT infrastructure solutions covering on-premise private cloud setups and public cloud integrations, including infrastructure applications.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: